Kushner says Israeli-Palestinian deal will not adhere to Arab Peace Initiative
DOHA (Reuters) - Reaching an Israeli-Palestinian deal along the lines of the Arab peace initiative will not be possible, requiring instead a stance between that and the Israeli position, White House senior adviser Jared Kushner said in an interview with Al Jazeera. 'I think we all have to recognise that if there ever is a deal, it's not going to be along the lines of the Arab peace initiative.
DOHA (Reuters) - Reaching an Israeli-Palestinian deal along the lines of the Arab peace initiative will not be possible, requiring instead a stance between that and the Israeli position, White House senior adviser Jared Kushner said in an interview with Al Jazeera.
"I think we all have to recognise that if there ever is a deal, it's not going to be along the lines of the Arab peace initiative. It will be somewhere between the Arab peace initiative and between the Israeli position," Kushner told Al Jazeera in an interview that will air on Tuesday.
As part of the Arab Peace Initiative, Arab states led by Saudi Arabia have called for a Palestinian state drawn along borders that pre-date Israel's capture of territory in a 1967 war as well as a capital in east Jerusalem and the right of return for refugees, points rejected by Israel.
The comments come ahead of a workshop in Bahrain to showcase the economic portion of Washington's long-awaited Arab-Israeli peace plan, a $50 billion development plan unveiled this week that has faced sharp criticism from Arabs across the region.
The lack of a political solution, which Washington has said would be unveiled later, has prompted rejection not only from Palestinians but in Arab countries with which Israel would seek normal relations.
Though Kushner has said that only the economic portions of the plan will be discussed in Manama, the comments offer a rare glimpse into what the political aspects of the peace plan may entail.
"All of the people I speak to, they talk about the Arab Peace Initiative, and again it was a great effort, but if that was where a deal was going to be made a deal would have been made a long time ago," said Kushner, who is President Donald Trump's son-in-law.
(Reporting by Eric Knecht; Editing by Leslie Adler)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment
SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.
CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.